Anne Xuan-Lan Nguyen

Dr. Anne Xuan-Lan Nguyen

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 July 2020 in BMJ Open Ophthalmology
Verified
Journal Article
Open access
PDF file
ANAnne Xuan-Lan Nguyen
Anne Xuan-Lan Nguyen
KGKalla Gervasio
Kalla Gervasio
AWAlbert Y. Wu
Albert Y. Wu
Objective Since the WHO declared the COVID-19 outbreak as a public health emergency, medical societies around the world published COVID-19 recommendations to physicians to ensure patient care and physician safety. During this pandemic, ophthalmologists around the world adapted their clinical and surgical practice following such guidelines. This original research examines all publicly available COVID-19 recommendations from twelve major ophthalmology societies around the world. Methods and analysis Twelve ophthalmology societies recognised by the International Council of Ophthalmology were included in this study. One society per each WHO region was included: the society selected was the one who had the highest number of national COVID-19 confirmed cases on 11 May 2020. In addition to these countries, the major ophthalmology society in each G7 country was included. Results Ten out of 12 major international ophthalmology societies from countries covering all six WHO regions have given recommendations regarding urgent patient care, social distancing, telemedicine and personal protective equipment when caring for ophthalmic patients during the COVID-19 pandemic. While all guidelines emphasise the importance of postponing non-urgent care and taking necessary safety measures, specific recommendations differ between countries. Conclusions As there is no clear consensus on ophthalmology guidelines across countries, this paper highlights the differences in international ophthalmic care recommendations during the COVID-19 pandemic. Knowledge of the differences in ophthalmic management plans will allow ophthalmologists and all eye care providers to consider the variety of international approaches and apply best practices following evidence-based recommendations during pandemics.

1 November 2021 in American Journal of Ophthalmology
Verified
Journal Article
Open access
ANAnne Xuan-Lan Nguyen
Anne Xuan-Lan Nguyen
SRSanyam Ratan
Sanyam Ratan
ABAnkita Biyani
Ankita Biyani
XTXuan-Vi Trinh
Xuan-Vi Trinh
SSSolin Saleh
Solin Saleh
AWAlbert Y. Wu
Albert Y. Wu
To assess the gender distribution of major ophthalmology society award recipients DESIGN: Retrospective, observational study METHODS: The study population included award recipients from 9 ophthalmologic societies: American Academy of Ophthalmology, American Association for Pediatric Ophthalmology and Strabismus, American Glaucoma Society, American Society of Cataract and Refractive Surgery (ASCRS), American Society of Ophthalmic Plastic and Reconstructive Surgery, American Society of Retina Specialists, American Uveitis Society, Cornea Society, and North American Neuro-Ophthalmology Society. A gender-specific pronoun and a photograph of each award recipient were extracted from professional websites to assign their gender. Main outcome measures were gender distribution by award society, year (1970-2020), type (lectureship or not), category (achievement, education, research contribution, research item, international member achievement, public service-global health, service to society), and training level. Out of 2,150 recipients for 78 awards, 1,606 (74.7%) were men and 544 (25.3%) were women. The proportion of women recipients increased from 0% in 1970 to 33.2% in 2020 (P < .001). Women representation varied within each society (P < .01), with ASCRS having the highest percentage (40.8%). Women received 11.0% of awards accompanied by a lecture. Women received a significantly greater proportion of research-related awards than achievement or service awards. Awards for trainees and early-career ophthalmologists had a greater proportion of women (39.8%) than the rest of the awards (21.5%) (P < .001). Overall, women received awards (25.3%) at a higher rate than the average 1970-2020 American gender distributions of ophthalmologists. However, women are still under-represented in many award categories and subspecialties.

17 May 2021 in Journal of Medical Internet Research
Verified
Journal Article
Open access
ANAnne Xuan-Lan Nguyen
Anne Xuan-Lan Nguyen
XTXuan-Vi Trinh
Xuan-Vi Trinh
SWSophia Y Wang
Sophia Y Wang
AWAlbert Y. Wu
Albert Y. Wu
Background: Clinical data in social media are an underused source of information with great potential to allow for a deeper understanding of patient values, attitudes, and preferences. Objective: This tutorial aims to describe a novel, robust, and modular method for the sentiment analysis and emotion detection of free text from web-based forums and the factors to consider during its application. Methods: We mined the discussion and user information of all posts containing search terms related to a medical subspecialty (oculoplastics) from MedHelp, the largest web-based platform for patient health forums. We used data cleaning and processing tools to define the relevant subset of results and prepare them for sentiment analysis. We executed sentiment and emotion analyses by using IBM Watson Natural Language Understanding to generate sentiment and emotion scores for the posts and their associated keywords. The keywords were aggregated using natural language processing tools. Results: Overall, 39 oculoplastic-related search terms resulted in 46,381 eligible posts within 14,329 threads. Posts were written by 18,319 users (117 doctors; 18,202 patients) and included 201,611 associated keywords. Keywords that occurred ≥500 times in the corpus were used to identify the most prominent topics, including specific symptoms, medication, and complications. The sentiment and emotion scores of these keywords and eligible posts were analyzed to provide concrete examples of the potential of this methodology to allow for a better understanding of patients’ attitudes. The overall sentiment score reflects a positive, neutral, or negative sentiment, whereas the emotion scores (anger, disgust, fear, joy, and sadness) represent the likelihood of the presence of the emotion. In keyword grouping analyses, medical signs, symptoms, and diseases had the lowest overall sentiment scores (−0.598). Complications were highly associated with sadness (0.485). Forum posts mentioning body parts were related to sadness (0.416) and fear (0.321). Administration was the category with the highest anger score (0.146). The top 6 forum subgroups had an overall negative sentiment score; the most negative one was the Neurology forum, with a score of −0.438. The Undiagnosed Symptoms forum had the highest sadness score (0.448). The least likely fearful posts were those from the Eye Care forum, with a score of 0.260. The overall sentiment score was much more negative before the doctor replied. The anger, disgust, fear, and sadness emotion scores decreased in likelihood, whereas joy was slightly more likely to be expressed after doctors replied. Conclusions: This report allows physicians and researchers to efficiently mine and perform sentiment analysis on social media to better understand patients’ perspectives and promote patient-centric care. Important factors to be considered during its application include evaluating the scope of the search; selecting search terms and understanding their linguistic usages; and establishing selection, filtering, and processing criteria for posts and keywords tailored to the desired results.

9 February 2023 in European Journal of Ophthalmology
Verified
Journal Article
Open access
Rohan Bir SinghRohan Bir Singh
Rohan Bir Singh
SSSachi Singhal
Sachi Singhal
SSShruti Sinha
Shruti Sinha
JCJunsang Cho
Junsang Cho
ANAnne Xuan-Lan Nguyen
Anne Xuan-Lan Nguyen
AAAniruddha Agarwal
Aniruddha Agarwal
Plasma cell dyscrasias are a wide range of severe monoclonal gammopathies caused by pre-malignant or malignant plasma cells that over-secrete an abnormal monoclonal antibody. These disorders are associated with various systemic findings, including ophthalmological disorders. A search of PubMed, EMBASE, Scopus and Cochrane databases was performed in March 2021 to examine evidence pertaining to ocular complications in patients diagnosed with plasma cell dyscrasias. This review outlines the ocular complications associated with smoldering multiple myeloma and monoclonal gammopathy of undetermined significance, plasmacytomas, multiple myeloma, Waldenström's macroglobulinemia, systemic amyloidosis, Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal gammopathy and Skin changes (POEMS) syndrome, and cryoglobulinemia. Although, the pathological mechanisms are not completely elucidated yet, wide-ranging ocular presentations have been identified over the years, evolving both the anterior and posterior segments of the eye. Moreover, the presenting symptoms also help in early diagnosis in asymptomatic patients. Therefore, it is imperative for the treating ophthalmologist and oncologist to maintain a high clinical suspicion for identifying the ophthalmological signs and diagnosing the underlying disease, preventing its progression through efficacious treatment strategies.

6 January 2021 in Canadian Journal of Ophthalmology
Verified
Journal Article
Closed access
ANAnne Xuan-Lan Nguyen
Anne Xuan-Lan Nguyen
ICIan Clark
Ian Clark
KDKarim F Damji
Karim F Damji
PHPatrick Hamel
Patrick Hamel
MBMarie-Lyne Bélair
Marie-Lyne Bélair
IHIsabelle Hardy
Isabelle Hardy

6 January 2025 in Biomedicines
Verified
Journal Article
Open access
PDF file
Merve KulbayMerve Kulbay
Merve Kulbay
NTNicolas Tuli
Nicolas Tuli
MMMassimo Mazza
Massimo Mazza
AJArmaan Jaffer
Armaan Jaffer
SJSarinee Juntipwong
Sarinee Juntipwong
HDHakan Demirci
Hakan Demirci
Intraocular malignant tumors are rare; however, they can cause serious life-threatening complications. Uveal melanoma (UM) and retinoblastoma (RB) are the most common intraocular tumors in adults and children, respectively, and come with a great disease burden. For many years, several different treatment modalities for UM and RB have been proposed, with chemotherapy for RB cases and plaque radiation therapy for localized UM as first-line treatment options. Extraocular extension, recurrence, and metastasis constitute the major challenges of conventional treatments. To overcome these obstacles, immunotherapy, which encompasses different treatment options such as oncolytic viruses, antibody-mediated immune modulations, and targeted immunotherapy, has shown great potential as a novel therapeutic tool for cancer therapy. These anti-cancer treatment options provide numerous advantages such as selective cancer cell death and the promotion of an anti-tumor immune response, and they prove useful in preventing vision impairment due to macular and/or optic disc involvement. Numerous factors such as the vector choice, route of administration, dosing, and patient characteristics must be considered when engineering an oncolytic virus or other forms of immunotherapy vectors. This manuscript provides an in-depth review of the molecular design of oncolytic viruses (e.g., virus capsid proteins and encapsulation technologies, vectors for delivery, cell targeting) and immunotherapy. The most recent advances in preclinical- and clinical-phase studies are further summarized. The recent developments in virus-like drug conjugates (i.e., AU011), oncolytic viruses for metastatic UM, and targeted immunotherapies have shown great results in clinical trials for the future clinical application of these novel technologies in the treatment algorithm of certain intraocular tumors.